The CHOP's research team findings support the hypothesis that rare AAV integration can contribute to human oncogenesis, which emphasizes the need to optimize gene delivery methods and monitor ...

The CEO of Caszyme, a biotech company in Vilnius, Lithuania, presented details of Cas12l, a novel compact Cas nuclease with a ...

The new CRISPR platform, called ΨDNA, reprograms Cas12 nucleases to recognize and act on RNA using a DNA-based guide scaffold ...

When these anchors are attached to cancer drugs, they attach to cell membranes and shrink tumors better than unmodified drug ...

These “living therapeutics” can sustain themselves in vivo and survive in biological environments including tumors, inflamed ...

Bristol Myers Squibb (BMS) will partner with Hengrui Pharma to co-develop 13 early-stage programs in oncology, hematology, and immunology, through a collaboration that could generate more than $15.2 ...

Researchers at the University of Pennsylvania developed ApexGO, an AI-powered system that optimizes antimicrobial peptides.

Researchers say findings may have relevance to understanding cell biological pathways that contribute to nerve repair after injury or neurodegeneration.

One of the winners of the 2026 ASGCT Catalyst Award, Kiran Musunuru, MD, PhD, delivered a sobering lecture on the legacy of ...

Sickle cell warrior Victoria Gray, the first patient to enroll in the Casgevy gene editing trial, shared some highs and lows ...

With faster and more affordable transcriptomic technologies, high-throughput RNA-seq can now be incorporated into oligo ...

Throughout this three-part webinar series, experts from USP and industry will share first-hand experiences, case studies, and ...